abstract: A great deal of evolutionary conservation has been found in the control of oocyte development, from invertebrates to women. However, little is known of mechanisms that control oocyte loss over time. Oocyte loss is often assumed to be a result of oocyte-intrinsic deficiencies or damage. In fruit flies, starvation results in halted oocyte production by germline stem cells and induces oocyte loss midway through development. When we fed wild-type flies the bacterial compound Rapamycin (RAP) to mimic starvation, production of new oocytes continued, but mid-stage loss sterilized the animals. Surprisingly, follicle cell invasion and phagocytosis of the oocyte preceded any signs of germ cell death. RAP-induced egg chamber loss was prevented when RAP receptor FKBP12 was knocked down specifically in follicle cells. Oogenesis continued past the mid-stages, and these mutants continued to lay embryos that could develop into normal adults. Hence, intact healthy oocytes can be destroyed by somatic cells responding to extrinsic stimuli. We termed this process inducible somatic oocyte destruction. RAP treatment of mouse follicles in vitro resulted in phagocytic uptake of the oocyte by granulosa cells as seen in flies. We hypothesize that extrinsic modes of oocyte loss occur in mammals.
Introduction
Oocyte loss is the process by which oocytes within an ovary-resident population die over time. In insects (Nezis et al., 2000; Mazzalupo and Cooley, 2006; Velentzas et al., 2007) , avians (Tilly et al., 1991) and mammals (Tilly, 2003 (Tilly, , 1998 Kim and Tilly, 2004) , apoptosis has been considered the primary mode of oocyte death; however, it is increasingly clear that autophagy also plays a role (Lobascio et al., 2007; Escobar et al., 2008; Rodrigues et al., 2009) . In mammals, the process of oocyte death within an ovarian follicle is referred to as follicular atresia. Studies of oocyte death have also revealed that phagocytic cells engulf and destroy dead and dying oocytes. These are the immediately adjacent somatic cells, follicle cells in insects (Mazzalupo and Cooley, 2006) and granulosa cells in mammals (Devine et al., 2000; Inoue et al., 2000) . It is often assumed that oocyte loss is driven by differential intrinsic oocyte 'quality' (see Section 3 below for definition) or damage. Oocytes of high 'quality' that are undamaged are thus thought to be selected for survival to fertilization while those of relative low 'quality' die and then are degraded.
In contrast, using the fruit fly (Drosophila melanogaster) model system, we have shown that intact oocytes-of the highest 'quality'-can be destroyed by somatic cells responding to environmental, oocyte-extrinsic stimuli (Thomson and Johnson, 2010) . In Section 2 below, we briefly compare and contrast ovarian function, oogenesis and oocyte loss between insects and mammals. In Section 3, we consider the concept of oocyte 'quality', and special features of oocyte loss in the human. Last, in Sections 4 and 5, we discuss oocyte loss in the fruit fly and ask whether our demonstration that oocyte-extrinsic factors can cause oocyte loss in Drosophila is relevant to mammals, including women.
Oogenesis and oocyte loss in mammals and insects
Monitoring oocyte number in different metazoan species across their life histories reveals that there are different strategies used to control the supply of eggs available for fertilization. While the process of oocyte development (termed oogenesis) differs greatly between insects and vertebrates, many clear developmental stages (Pepling et al., 1999; Pepling and Spradling, 2001; Pepling, 2006) and the genes that regulate them (Noce et al., 2001; Pepling et al., 2007; Baskind et al., 2009 ) are highly conserved (Noce et al., 2001; Huang et al., 2003; Pepling et al., 2007; Baskind et al., 2009) . Table I contains a brief summary of conserved gene products involved in oogenesis and ovarian function and compares and contrasts their expression and function between the fruit fly Drosophila melanogaster and mammals.
The mammalian ovary is often a 'radial' arrangement, where follicles containing oocytes grow within and ovulate radially from an external cortex (Fig. 1A) 
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Intrinsic and extrinsic mechanisms of oocyte loss cells (PGC) specified during early gestation. After PGC migration from the yolk sac and colonization of the urogenital ridge [see Richardson and Lehmann, (2010) for a review], they undergo a period of proliferation and then initiate the specialized meiotic cell cycle in females. The last rounds of PGC divisions are characterized by incomplete cell division, and 'cysts' of oocytes connected by cytoplasmic bridges are found (Pepling and Spradling, 2001 ). This situation is very reminiscent of the oocyte-nurse cell arrangement in Drosophila (below). Oocyte death within cysts and increased interaction with surrounding somatic pregranulosa cells follow, leaving individual oocytes now surrounded by a single layer of flattened epithelial-like somatic cells (pregranulosa cells). These Prophase I-arrested oocytes are referred to as primordial oocytes and reside in primordial follicles. Although a cohort of follicles begins to grow during prepubertal life, Prophase I arrest remains in effect until puberty. There is some question whether mammals have a fixed pool of oocytes endowed at birth that represent all those available for ovarian function and potential conception. Multiple groups have now shown that the generation of new immature oocytes can be detected during adult life and that immature oocytes can be regenerated by female germline stem cells (fGSCs) (Johnson et al., 2004; Zou et al., 2009; Pacchiarotti et al., 2010) after destruction. Further, it has been shown that fGSCs can be isolated from the adult ovary, and are capable of being cultured long-term in vitro, of being transplanted to recipient mice, and of giving rise to oocytes capable of supporting offspring production (Zou et al., 2009) . A crucial question is whether fGSCs normally produce new oocytes to physiologically support oocyte production in adults or are only relevant to experimental models. As mentioned, oocyte loss occurs in mammals in a process termed follicular atresia (Hunt and Hassold, 2008) . Follicles and oocytes undergoing atresia are readily identified using morphological and molecular tools, and a great deal of information is available about the genetic control of the process.
During mammalian follicular atresia, both the oocyte and the somatic cells of the ovary exhibit hallmarks of cell death. Genes known to control apoptosis (Matikainen et al., 2001; Pru and Tilly, 2001; Guo et al., 2002; Morrison and Marcinkiewicz, 2002; Sakata et al., 2003) and autophagy (Yaba et al., 2008; Rodrigues et al., 2009) are expressed in both the oocyte and granulosa cells. For this reason, it is difficult to determine whether oocyte loss necessarily occurs due to oocyte intrinsic or extrinsic (granulosa cell) factors. Tissue-specific tools (mice with oocyte or granulosa specific expression) are available now that can be used to address this question. What is clear, however, is that coordinated cell death signaling is required so a subset of phagocytic granulosa cells survive long enough to clear the dead and dying cells of the follicle (Devine et al., 2000; Inoue et al., 2000) .
The insect ovary, including that of the fruit fly Drosophila melanogaster, is essentially a 'linear' arrangement (Fig. 1B , compare with 'radial' mammalian ovary). Like mammals, specification of PGCs occurs during early development. In adults, each ovary contains a bundle of parallel ovarioles where egg chamber development occurs; germline stem cells (GSC) are present at the ovariole anterior in a structure termed the germarium (green). Here, new egg chambers are produced and development occurs in a 'chain', from anterior to posterior, where mature, fertilization-competent eggs are found. At posterior, the oviduct (white dashed line), fertilization organ, and laying apparatus are found.
Unlike mammals where one germ cell is found per follicle, fly oocytes grow in an egg chamber (See Fig. 2A for an example of an intact mid-stage egg chamber). Fly egg chambers consist of 16 germ cells surrounded by an epithelial follicle cell monolayer. Early in development, 1 germ cell is selected to be the oocyte, and the remaining 15 cells are specified to be nurse cells. Interestingly, this is reminiscent of prenatal stages of oogenesis during follicle formation in the mouse (Pepling and Spradling, 2001; Pepling et al., 2007) . Like the ovariole, egg chambers have characteristic polarity, with the oocyte taking the posteriormost position ( Fig. 2A oocyte and degenerate, resulting in a single mature fertilizationcompetent egg shortly thereafter. After mating, female flies can store 1000 sperm cells. Eggs are fertilized as they complete development, and as many as 50 embryos can be laid in a single day.
Insects are well known to produce new oocytes throughout life via a defined GSC niche [see Fuller and Spradling (2007) for a review]. Oocyte loss is also clearly identifiable in the fruit fly ovary by morphological cues, DNA staining (See Fig. 2B ), and more sophisticated transgenic tools (Mazzalupo and Cooley, 2006) . Degrading egg chambers are often seen at the 'mid-stages' of development (Cartoon ,  Fig. 1B) ; this can interrupt egg production in individual ovarioles, or throughout the entire ovary. While many features of mammalian and insect oocyte production appear to be conserved developmentally, there are indeed very significant anatomical differences to consider; for example, flies would be of limited use when considering the intricacies of mammalian follicle maturation. However, new data suggest that flies may be a useful model for the study of oocyte loss.
Oocyte intrinsic 'quality', 'health' and damage
Oocyte quality
It is helpful when considering oocyte loss to use the jargon terms oocyte 'quality' or 'health'. These terms refer to the (inferred) intrinsic Figure 1 Comparison between mammalian adult ovarian anatomy and that of the fruit fly Drosophila. (A) depicts the mammalian ovary and its 'radial' pattern of follicle development (green arrows). The follicle-containing ovarian cortex ('C') overlies the interior medulla ('M'). The inset at center shows presumptive female GSCs, their maintenance as a regenerative population and their potential role in generating new oocytes during post-natal life. At the top of (B), a darkfield light photomicrograph of a fly ovary pair is shown (A-anterior, P-posterior), overlaid with a cartoon representation of a single ovariole. The muscle sheath that encloses the ovariole is shown by a solid white line, the common oviduct by a dashed white line, and the path of a mature egg which will be internally fertilized as it passes the oviduct by a yellow arrow. At the bottom, the cartoon ovariole has been extended so that individual regions may be highlighted. A yellow crescent is shown at left (anterior), representing the GSC niche of the germarium. GSCs undergo self-renewal in this niche (circular arrow) and also produce the germ cells of new egg chambers (straight arrow). Egg chamber growth continues posteriorly. Mid-stage (red) egg chambers are noted for their susceptibility to degradation and death; and the outcomes of RAP treatment of flies and starvation are compared below. genetic, epigenetic and cytoplasmic characteristics required for the completion of development and capability of producing a normal offspring. Healthy oocytes of high quality thus can complete the meiotic and cytoplasmic maturation program, while those of low quality cannot. In mammals, there is thought to be a mechanism that ensures the selection of and survival to ovulation of healthy oocytes at the expense of those that are unhealthy, a prospect that we consider here. Many experimental models have been used to reveal the genes and signaling requirements for oocyte development, showing the mechanisms and molecules required to produce developmentally mature eggs. It is still unclear what factors control the production of high-quality mature eggs.
In humans, a sharp dropoff in the number of oocytes capable of giving rise to offspring occurs at around age 35 (Conway, 1997; Hunt and Hassold, 2008) . The decline in oocyte quality correlates with age-related changes in meiotic spindle morphology and chromosome alignment in all women (Hunt and Hassold, 2008) . These measures show that the ability to complete meiosis properly so that offspring development may occur has been compromised. This problem is not alleviated by ovarian stimulation regimes in the clinic. There, retrieval of large numbers of poor quality oocytes (as directly measured by their ability to give rise to embryos or offspring after fertilization) is likely to occur (Broekmans et al., 2009) . As a woman passes age 35, menstrual cycles including ovulation continue for years with only poor quality oocytes present to participate in follicle development.
Different groups have shown that signaling molecules produced by the oocyte are the primary drivers of follicle development and survival (Matzuk et al., 2002; Su et al., 2009) . For example, oocyte-specific transforming growth factor (TGF-b) signaling molecules such as growth differentiation factor (GDF-9) (Pangas and Matzuk, 2004) , also (see Table I ) are required for follicle development and fertility in mammals. This has led to the reasonable consensus that the production of such molecules is reflective of an oocyte's quality, and to models where altered production of growth cues by certain oocytes correlate with oocyte loss. Oocyte damage, as caused by aging, exposure to toxicants or to modalities such as radio and chemotherapies (mouse: Mazaud et al., 2002; Jurisicova et al., 2006; Oktem and Oktay, 2007; insect: Steiner and Wurgler, 1979; StaevaVieira et al., 2003, mentioned above) might then affect the production of these oocyte-derived factors, and as a consequence, result in oocyte loss.
For example, Cansu et al. (2008) recently showed that treatment of Wistar rats with either of the antiepileptic drugs valproate or oxcarbazepine results in a reduction in follicle numbers compared with controls. Treatment with either drug also resulted in reduced GDF-9 immunostaining versus vehicle-treated control animals. Granulosa cells in drug-treated animals also showed significantly increased expression of the pro-apoptosis marker p53 and increased terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining (direct visualization of apoptotic cells). To determine the mechanism of follicle loss, one must determine which cell type(s) were affected by the drug. Did these drugs damage the oocyte, the granulosa cells, or both? It is likely that the induced oocyte loss is occurring due to some feedback between the oocyte and granulosa cells (Su et al., 2004) . As will be further illustrated in the next example, this question needs much more attention.
The effects of the chemotherapeutic agent Doxorubicin (DOX) were assessed using a mouse model (Ben-Aharon et al., 2010) . Those authors determined that DOX causes widespread damage to mouse ovarian follicles as evidenced by increased active-caspase 3 expression and TUNEL staining for apoptosis as soon as 12 h postinjection. Treated animals were found to harbor fewer follicles than controls injected with saline 1 month after injection. Interestingly, DOX-treated animals continued to ovulate (oocytes that) '. . . revealed neither morphological nor chromosomal changes compared with oocytes ovulated by control mice (data not shown)'. This study brings to mind additional questions: why do some follicles at equivalent developmental stages survive, while others die when challenged with the same concentration of drug? What cell types does DOX damage: oocytes, somatic cells or both? Did DOX damage some oocytes first, and then the somatic cells of follicles responded by clearing the dead oocyte and dying follicle, as an oocyte-intrinsic model would require? Or is it possible that treatments like DOX do not damage oocytes at all, but instead stimulate adjacent somatic cells to destroy intact oocytes (as will be seen below)? By answering these questions, we will be better equipped to protect follicles during such treatment regimens in women.
Features of oocyte loss in the human
During the human reproductive years, one oocyte in a growing cohort develops into a mature oocyte and survives to ovulate each menstrual cycle. Companion growing follicles within a cohort regress and die at some point during the development. Optimally, functioning ovaries contain waves of growing and regressing follicles that produce the premenopausal hormonal and signaling milieu (Conway, 1997) . Prior to the reproductive years, however, a staggering amount of oocyte loss takes place as part of the normal physiological development of the ovary.
Human females generate 7 million immature oocytes during fetal development; this number drops to 2 million by birth during the process of follicle formation, a million of which appear intact (Baker, 1963) . By puberty, this number has decreased to perhaps one hundred thousand, after which growth within follicles is countered by further attrition (Conway, 1997) . Thus the vast majority of oocytes are not relevant to fertility, existing only within the ovary, never to be ovulated. As the cessation of ovarian function (in humans, the menopause, at approximately age 55) approaches, the loss of oocytes accelerates, until a threshold number of follicles remain that are incapable of maintaining the hormonal milieu necessary for continued ovarian cycling.
Menopause that begins prior to age 40 is referred to as premature ovarian failure (POF) (Conway, 1997) . Unexplained POF occurs in up to 1% of the world's female population (and in 1 in 1000 women between 15 and 29 years of age) (Skillern and Rajkovic, 2008) . Significant health and well-being challenges face that 1% for the remainder of life. In addition to the continuum of 'natural' oocyte loss, several factors are known that can induce the loss of oocytes in girls and women.
Radiotherapy (Snmezer and Oktay, 2008) and certain chemical (Hoyer et al., 2001 ) and chemotherapeutic agents (Beard et al., 1984; Sklar, 2005) (Gosden et al., 2007) assessed POF onset in cohorts of MZ (n ¼ 270) and dizygotic (DZ, n ¼ 158) twins. Approximately 4% of both MZ and DZ twins experienced POF before 40 years of age (a significantly higher rate than the 1% seen in non-twins). Interestingly, a similar fraction (5%) of both MZ and DZ twins had a discordance between their age of onset of POF. This fraction had an average 15 year difference, where one twin experienced ovarian failure at 35 and the other at 50. That MZ and DZ twins display such a wide discordance in age at POF but a similar span between types of twins suggests that non-inherited factors play a role in its onset. All of the above being said, very little is known of the criteria by which (why) and the cellular processes (how) by which oocytes are lost.
Nutritional control of oocyte production and loss in Drosophila melanogaster
As our group began to focus on oocyte loss, we reasoned that fly starvation would be a rapid, reproducible system to monitor oocyte loss and determine the genetic underpinnings of the process. Egg production in Drosophila has been shown to be regulated by nutritional (amino acid) availability, and endocrine and paracrine hormone signaling (Drummond-Barbosa and Spradling, 2001). Drosophila mid-stage egg chamber death was noted in the mid-1970s (Georgi and Deri, 1976) . Later work found that starvation can result in the activation of death pathways that execute egg chamber death (Mazzalupo and Cooley, 2006; Pritchett et al., 2009) . Simple models such as moving flies from juice agar plates with yeast supplementation to juice agar plates lacking yeast result in significant mid-stage egg chamber death.
The groups of Allan Spradling and Daniela Drummond-Barbosa showed that the rate of production of new egg chambers by the germ and somatic stem cells of the germarium slows when flies are placed under starvation conditions (Drummond-Barbosa and Spradling, 2001; LaFever and Drummond-Barbosa, 2005) . Further work by DrummondBarbosa revealed that starvation results in a reduction of neural expression of Drosophila insulin-like peptides that directly up-regulate GSC proliferation and the production of new egg chambers in the germarium (Fig. 1B, green) . Concurrently upon starvation, immature egg chambers (containing oocytes) degenerate and die within 'mid-stage' (Stage 8/9) egg chambers (Drummond-Barbosa and Spradling, 2001), see (Pritchett et al., 2009) for review (Fig. 1B, red) . We initially sought to determine the relative impact of decreased 'production' versus the increased oocyte loss due to nutritional withdrawal upon egg laying.
Our initial results using adult female flies were consistent with previous observations (e.g. slowed production and increased destruction), but we found that the number of egg chambers induced to undergo destruction was quite variable between flies. We sought to develop a more precise, reproducible model. Our experience with the pharmacological agent Rapamycin (RAP) in mice (Yaba et al., 2008) led us to test whether its inhibition of the Drosophila Target of Rapamycin (dTOR) kinase might replicate the effects of starvation in a more reproducible fashion. During periods of compromised nutrition, activity of TOR kinase is decreased, leading to a general inhibition of translation (Gingras et al., 2001) and reduced cell proliferation (Wiederrecht et al., 1995) . RAP inhibits TOR by binding an intracellular receptor, immunophilin FKBP12 (Jacinto et al., 2004) . For these reasons, experimental manipulation of TOR signaling is often used to mimic nutritional conditions. The mammalian TOR kinase (mTOR) has been implicated in the control of ovarian follicle development (Alam et al., 2004) and growth (Yaba et al., 2008) .
To determine potential effects of RAP upon egg chamber production and growth, we evaluated mitotic figures in mated wild-type flies housed on yeast food that contained 10 mM RAP or vehicle. Alternatively, flies were 'starved' by withholding yeast. We found that embryo laying halted when flies were starved or housed on the drug. As starvation is known to stop the production of new egg chambers by GSC, we examined ovarioles for markers of proliferation. A lack of production of new egg chambers would result in a lack of mitotic GSC and mitotic somatic cells of new growing egg chambers. Strikingly, unlike starved controls, RAP treatment did not affect the production of new egg chambers by GSC as visualized by similar numbers of mitotic cells to vehicle-treated flies. That RAP had this effect was fortuitous for further experiments, as the result was akin to an assembly line where oocytes continue to be produced, only to be efficiently destroyed, over and over, at the mid-stages. Our model is thus the first to allow the study of oocyte loss independent of effects upon GSC. Like starvation, RAP's effect was found to be reversible, as removing flies from RAP to food lacking the drug resulted in a recovery of oogenesis and embryo laying.
We then assessed the effects of RAP treatment using previously identified features (Mazzalupo and Cooley, 2006) of degenerating midstage egg chambers. Figure 2 compares mid-stage egg chambers from vehicle-fed ( Fig. 2A) and RAP-fed (Fig. 2B) flies. Intact egg chambers are characterized by a well-organized monolayer of epithelial follicle cells surrounding the oocyte and nurse cells ( Fig. 2A) . We found that the first sign of degeneration during RAP ingestion was seen in posterior follicle cells (PFCs) of Stages 8 and 9 egg chambers. RAP ingestion consistently induced a loss of PFC epithelial apicobasal polarity (LOP) characterized by PFC 'piling up' and taking on a disorganized appearance (Fig. 2B) . After 'piling up', follicle cells could be seen invading the oocyte (Fig. 2B, yellow arrowheads) . Egg chambers exhibiting posterior LOP appeared otherwise intact, with the nuclei of nurse cells having a normal (non-apoptotic) appearance (Fig. 2B,*) . After these initial steps, significant egg chamber degradation occurred, resulting in a small remnant characterized by apoptotic cells and phagocytic follicle cells (Mazzalupo and Cooley, 2006; Thomson and Johnson, 2010) . This suggested that RAP treatment was causing egg chamber destruction that began in a somatic follicle cell-specific manner.
An oocyte-extrinsic mechanism of oocyte loss in Drosophila melanogaster
The effect of Rapamycin is somatic follicle cell-specific After determining that RAP ingestion allowed us to reproducibly assess egg chamber destruction, we engaged in a two-pronged approach. We first wanted to determine if the oocyte destruction Intrinsic and extrinsic mechanisms of oocyte loss induced by RAP was due to the compound acting through its known receptor, immunophilin FKBP12. In order to test this, GAL4: upstream activating sequence (UAS) system was used to drive inhibitory RNAi directed against FKBP12 specifically in the somatic follicle cells adjacent to the oocyte. Fortuitously, GAL4 'driver' fly lines are available that direct expression to different regions of follicle cells. This allowed the knockdown of FKBP12 in either posterior or anterior populations of follicle cells. Because the first stage of oocyte destruction was the LOP in PFCs, we hypothesized that knockdown of FKBP12 in PFC would result in lessened LOP and lessened follicle cell invasion into the oocyte. Accordingly, that controls using an anterior follicle cell (AFC)-specific promoter should not prevent the process.
Our hypothesis proved correct, as flies bearing a PFC-specific GAL4 driver and UAS-FKBP12 RNAi had significantly increased mid-stage egg chambers with PFC in normal monolayers (RNAi; flies expressing the driver or UAS:RNAi alone). Suprisingly, these mutants continued to lay embryos when housed with males upon 10 mM RAP. This concentration of RAP obliterated embryo laying by wild-type flies and controls (flies expressing an AFC-specific GAL4 driver and UAS:FKBP12).
The cartoon in Fig. 3 summarizes the outcome of this experiment. As the GAL4:UAS system used is known to be effective in somatic cells but not the germline (Brand and Perrimon, 1993; Van Doren et al., 1998) , and RNAi has been shown to be non-functional in oocytes until much later in oogenesis (Stage 14, Kennerdell et al., 2002) , it is likely that rescued laying was a consequence of blocking the effect of RAP on somatic PFCs and not from any unanticipated knockdown effects within oocytes. We therefore reasoned that we could use this system to determine whether intrinsic oocyte damage is in fact a prerequisite for oocyte loss.
The PFC-specific FKBP12 knockdown system to was used address the question of oocyte-intrinsic damage as follows. If maternal RAP damaged oocytes during their development, laid embryos would be damaged and incapable of developing into adults. To test this, laid embryos were moved from PFC FKBP12 knockdown flies to fresh standard fly food containing no RAP. This was necessary as RAP has been shown to inhibit larval development and survival to adulthood . Ninety percent of embryos hatched and developed into normal adults (compared to 93% of wild-type control embryos from untreated mothers that were similarly moved to fresh fly food developed into adults). This result shows that maternal RAP treatment does not compromise an oocyte's (e.g. the germ compartment's) ability to give rise to offspring. Instead, oocyte-extrinsic cues can induce somatic follicle cells to destroy oocytes that are otherwise in perfect 'health'. Further, this result supports a model where flies control their oogenesis and thus fecundity in a manner compatible with the survival of their offspring . This concept is revisited below in 'Final thoughts'. In the second part of our approach, we began to screen for known and novel genes outside of the TOR signaling pathway that are required for oocyte loss in the presence of RAP.
Epithelial polarity and oocyte loss
Again, the LOP of follicle cells was the first step in the process of inducible somatic oocyte destruction (ISOD). We hypothesized that altered regulation of epithelial polarity might interrupt the ISOD process and targeted this functional category to begin our screen. Fly mutants were readily available from the publicly-accessible Bloomington Drosophila Stock Center (http://flystocks.bio.indiana.edu/) or were immediately provided by individual laboratories. Scribble (scrb) and discs large (dlg) mutants were evaluated as these are among the genes that control the polarity of the follicle cell layer (Asśemat et al., 2008; Zhao et al., 2008b) by participating in junctional complexes between epithelial cells. We also evaluated members of the Salvador-warts-hippo network of proteins (Udan et al., 2003; Meignin et al., 2007; Polesello and Tapon, 2007) , including the tumor suppressor Merlin/Neurofibromin 2 (mer) (LaJeunesse et al., 1998; Hamaratoglu et al., 2006) and Warts (wts) (MacDougall et al., 2001 ). These genes have been shown to be required for establishing proper oocyte axis formation by their action in PFC. Mutant and control wild-type flies were fed RAP, and embryo laying was again assessed.
Flies heterozygous for functional alleles of several of candidate genes rescued embryo laying in flies fed RAP. Heterozygous dlg (null allele dlg lv55 /+), mer/+ and wts/+ mutants showed significantly increased embryos laid per fly versus wild-type controls. In contrast, scrb mutants did not lay embryos when fed RAP. Examination of ovaries from rescuing mutants showed the expected rescue of oogenesis; these mutants had vastly fewer degenerating egg chambers when fed RAP than controls. Control western blots confirmed that these flies were not simply more resistant to RAP, as the phosphorylation of the dTOR kinase substrate p70S6-kinase is greatly diminished in RAP-treated flies of each strain. This suggested that the reduced ISOD seen in mutants is unlikely to be a result of de-regulated TOR signaling as a result of each mutation. This screen has thus detected the first of several genes expressed in PFC that are required for ISOD. It appears that if the initial loss of epithelial polarity is blocked, the entire degradative process of ISOD can be prevented (Fig. 3) .
Is ISOD conserved in mammals?
Wondering whether this process was applicable to higher organisms, we assessed the disposition of small pre-antral mouse follicles after in vitro culture in RAP or vehicle. Culture of follicles in 100 nM RAP caused three dose-dependent effects. First, some follicles maintained their spherical shape, but the oocyte was degraded over time and displaced by neighboring granulosa cells. This outcome suggested that oocyte invasion and destruction by adjacent somatic cells also occurs in the mouse. It remains to be seen whether a somatic cellspecific response to RAP is sufficient to cause oocyte destruction as seen in the fly. Second, follicles were seen where the granulosa cell layers did not proliferate, but the structure remained intact. Both types of follicles were confirmed as viable using a biochemical assay (after Yaba et al., 2008) . Last, treatment with a higher dose of RAP (200 nM) resulted in a fraction of follicles that lost spherical integrity and plated down onto the culture dish. In those cases, the oocyte was most often intact, having been 'ejected' from the follicle. It is true that the radial growth pattern of the granulosa cell layers of mammalian follicles is quite different from the polarized monolayer of fly follicle cells. However, plating down can be interpreted as a loss of epithelial polarity; this bears further study. Mouse orthologues of scrb and dlg (Huang et al., 2003) have been detected within mouse ovarian follicles. It is therefore possible that both the ISOD process and the first genes known to control it are conserved between the mouse and the fly.
Final thoughts
Intrinsic oocyte quality clearly plays a key role in determining fertility in females of all metazoan species. However, we have provided evidence that a mechanism of oocyte loss exists where surrounding somatic cells can destroy oocytes of normal quality in response to an extrinsic signal, RAP. It is now worth considering whether exposure to environmental factors over time might stimulate a fraction of granulosa cells to destroy their adjacent oocytes independent of oocyte quality or direct oocyte damage.
While there are large anatomical and physiological differences between mammalian and insect ovaries (Fig. 1) , the fruit fly model system has considerable utility when considering oocyte loss. The strong conservation of genes and their functions (Table I) between flies and mammals throughout oogenesis is clear. Also, in both cases, the cells adjacent to the oocyte take on a phagocytic phenotype when egg chambers and follicles undergo degradation and clearance. The very short generation time of Drosophila and its correspondingly rapid pace of oogenesis allows for quick, inexpensive experimentation. Many tissue-specific transgenic and/or knockdown tools relevant to the arena of oogenesis and ovary function are freely available from laboratories as well as central repositories. Finally, Drosophila lends itself to comparatively rapid large scale genetic screens for the detection of gene function. We have embarked on screening the entire fly genome for known and novel Material. An intact egg chamber (top) receives a signal that activates the degradative program. First, posterior follicle cells undergo a rearrangement in epithelial polarity (middle), and successive stages of degradation result in an egg chamber remnant. RAP treatment sterilizes wild-type female flies by blocking all egg production in this manner. *If the response to RAP is blocked in follicle cells, or the expression of individual epithelial polarity genes are reduced, ISOD is prevented, egg development continues, and fertility is rescued in the presence of the drug.
Intrinsic and extrinsic mechanisms of oocyte loss genes required for the process of ISOD and oocyte loss. Some amount of this new information should translate to our understanding of oocyte loss in mammals, including women.
Halting oogenesis when food is absent or when an environmental chemical like RAP is present is an advantageous reproductive strategy for the fly. In both cases, the local environment would not support the survival of laid offspring. When a food substrate for embryo laying is encountered that is compatible with offspring survival, oogenesis (and fecundity) begins anew. Thus, there is no need to 'monitor' the quality of individual oocytes, flies simply destroy oocytes during unfavorable conditions. Could this strategy apply to mammals? To address this question, we reconsider the concept of oocyte loss as a 'quality control mechanism'.
In mammals, oocyte loss occurs as a consequence of normal development, baseline follicle atresia, and also due to insult. Because oocytes of high quality are ovulated during the reproductive years, it is logical to presume that oocytes that are lost during fetal life and to follicle atresia are of lower quality. However, folliculogenesis and ovulation continue in mammals even when oocyte quality is demonstrably poor. This is found in mouse knockout models (Le Naour et al., 2000; Ledent et al., 2005; Lee et al., 2007; Tomasini et al., 2008) , and in mammalian models of environmental/chemotherapeutic insult (Hunt et al., 2003; Cansu et al., 2008) , even when induced oocyte aneuploidy favors subfertility and infertility (Hunt et al., 2003) .
Perhaps most instructively, the ovulatory cycle continues in the years between age 35 and menopause in humans, when oocytes are well known to be decreasing in quality. The finding that oocyte number and the age of menopause onset can differ widely in MZ twins (Gosden et al., 2007) suggests that non-inherited factors are important causes of oocyte loss. If we presume that twins have comparable oocytes, oocyte-specific quality control cannot explain such divergent rates of loss. With these factors in mind, it is difficult to understand how oocyte-intrinsic quality can be the primary factor that drives oocyte loss. Instead, we favor a model supported in Drosophila, where ovarian somatic cells act as both environmental sensors and oocyte executioners, controlling oocyte loss in an oocyte extrinsic-manner.
If mammalian oocytes can be destroyed due to somatic cell (e.g. granulosa cell) specific effects independently of oocyte quality, we may find new ways to protect and extend fertility. First, we must identify the triggers that RAP and other environmental stimuli activate to cause somatic cell destruction of oocytes in flies, and test for evolutionary conservation in mammals. If we can block the activation of this process prospectively, we may be able to protect some undetermined fraction(s) of oocytes within the ovaries of women who might otherwise suffer POF. Further, as we determine the genetic requirements for ISOD, and uncover the signal transduction mechanisms involved in the process, we may uncover polymorphisms or other factors that lead to differential susceptibility in women. For example, we can hypothesize that certain women, due to their carrying certain alleles of epithelial polarity genes, are particularly sensitive to ISOD, and at greater risk for oocyte loss. Perhaps one day we can identify these women and offer them prophylactic protection against what will be viewed as a preventable disease and no longer an idiopathic condition for one percent of the human female population.
